A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
Kyong Hwa Park,Joohyuk Sohn,Seoul Lee,Jin‐hong Park,Seok Yun Kang,H. Y. Kim,I. H. Park,Young Hyun Park,Yang Im,H. J. Lee,Daesik Hong,S. Park,Seong Hoon Shin,Hyuk-Chan Kwon,Jae Hong Seo
出处
期刊：Investigational New Drugs [Springer Science+Business Media] 日期：2013-05-15卷期号：31 (5): 1300-1306被引量：25
PDF的下载单位、IP信息已删除
(2025-6-4)
水煮电吹风
cdercder
Kao
GingerF
唠叨的大门
Criminology34
无极微光
v0id
OK
YifanWang
学术文献互助
null
渡人舟
秋风
潇洒的惋清
Nole
掐钰
aajhajkahna
罗Eason
zjh33
皖公网安备34019202002308
